Literature DB >> 25857406

MiR-218 mediates tumorigenesis and metastasis: Perspectives and implications.

Ying-fei Lu1, Li Zhang2, Mary Miu Yee Waye3, Wei-ming Fu4, Jin-fang Zhang5.   

Abstract

MicroRNAs (miRNAs) are a class of small non-coding RNAs that negatively regulate gene expression at the post-transcriptional level. As a highly conserved miRNA across a variety of species, microRNA-218 (miR-218) was found to play pivotal roles in tumorigenesis and progression. A group of evidence has demonstrated that miR-218 acts as a tumor suppressor by targeting many oncogenes related to proliferation, apoptosis and invasion. In this review, we provide a complex overview of miR-218, including its regulatory mechanisms, known functions in cancer and future challenges as a potential therapeutic target in human cancers.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Metastasis; Target genes; Tumorigenesis; miR-218

Mesh:

Substances:

Year:  2015        PMID: 25857406     DOI: 10.1016/j.yexcr.2015.03.027

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  25 in total

1.  Loss of motoneuron-specific microRNA-218 causes systemic neuromuscular failure.

Authors:  Neal D Amin; Ge Bai; Jason R Klug; Dario Bonanomi; Matthew T Pankratz; Wesley D Gifford; Christopher A Hinckley; Matthew J Sternfeld; Shawn P Driscoll; Bertha Dominguez; Kuo-Fen Lee; Xin Jin; Samuel L Pfaff
Journal:  Science       Date:  2015-12-18       Impact factor: 47.728

Review 2.  The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.

Authors:  Keiichi Koshizuka; Toyoyuki Hanazawa; Ichiro Fukumoto; Naoko Kikkawa; Yoshitaka Okamoto; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-08-25       Impact factor: 3.172

Review 3.  Emerging Role of MicroRNAs in mTOR Signaling.

Authors:  Yanjie Zhang; Bo Huang; Hui-Yun Wang; Augustus Chang; X F Steven Zheng
Journal:  Cell Mol Life Sci       Date:  2017-02-25       Impact factor: 9.261

4.  SLIT2 promoter hypermethylation-mediated SLIT2-IT1/miR-218 repression drives leukemogenesis and predicts adverse prognosis in myelodysplastic neoplasm.

Authors:  Ting-Juan Zhang; Zi-Jun Xu; Xiang-Mei Wen; Yu Gu; Ji-Chun Ma; Qian Yuan; Jiang Lin; Jing-Dong Zhou; Jun Qian
Journal:  Leukemia       Date:  2022-07-29       Impact factor: 12.883

5.  [MicroRNA-218 promotes osteosarcoma cell apoptosis by down-regulating oncogene B lymphoma mouse Moloney leukemia virus insertion region 1].

Authors:  Gui-Hua Lai; Ai-Lan Huang; Zhi Zhao; Xing-Hao Lu; Wen-Xuan Zu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-05-20

6.  Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.

Authors:  L Yang; Q Xu; H Xie; G Gu; J Jiang
Journal:  Clin Transl Oncol       Date:  2015-11-19       Impact factor: 3.405

7.  Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.

Authors:  Ichiro Fukumoto; Naoko Kikkawa; Ryosuke Matsushita; Mayuko Kato; Akira Kurozumi; Rika Nishikawa; Yusuke Goto; Keiichi Koshizuka; Toyoyuki Hanazawa; Hideki Enokida; Masayuki Nakagawa; Yoshitaka Okamoto; Naohiko Seki
Journal:  J Hum Genet       Date:  2015-10-22       Impact factor: 3.172

Review 8.  MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations.

Authors:  Jennifer Louten; Michael Beach; Kristina Palermino; Maria Weeks; Gabrielle Holenstein
Journal:  Biomark Insights       Date:  2016-01-18

9.  A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.

Authors:  Kinya Okamoto; Masahiko Koda; Toshiaki Okamoto; Takumi Onoyama; Kenichi Miyoshi; Manabu Kishina; Jun Kato; Shiho Tokunaga; Taka-Aki Sugihara; Yuichi Hara; Keisuke Hino; Yoshikazu Murawaki
Journal:  PLoS One       Date:  2016-05-02       Impact factor: 3.240

10.  ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis.

Authors:  Kuo-Liang Chiu; Ting-Ting Kuo; Qian-Yu Kuok; Yu-Sen Lin; Chung-Hung Hua; Chen-Yuan Lin; Pei-Yuan Su; Liang-Chuan Lai; Yuh-Pyng Sher
Journal:  Sci Rep       Date:  2015-11-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.